Domestic migraine drug market expected to grow

Stimulated by the recent strategic alliances between CJ/Yuyu Pharm and GlaxoSmithKline over the exclusive distribution of Naramig and Imigran in domestic pharmaceutical market, Korea's anti-migraine drug market is likely to grow in anticipation of generics introduction by new entrants, amidst mounting perception of migraine by the citizens.

CJ and Yuyu Pharm plans to target each of their sal...